Cargando…
Low Testosterone in Males May Warrant Liver Health Assessment and Intervention
Low testosterone (T) is a serum marker of hypogonadism. Reportedly, diabetes mellitus, cardiovascular disease, peripheral artery disease, hypertension, hyperlipidemia, depression, obesity, metabolic syndrome, sleep apnea, chronic obstructive pulmonary disease (COPD), and opioid dependency, are assoc...
Autores principales: | DelConte, Anthony, Bruno, Benjamin J, Kim, Kilyoung, Vangara, Kiran, Papangkorn, Kongnara, Chidambaram, Nachiappan, Patel, Mahesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265986/ http://dx.doi.org/10.1210/jendso/bvab048.595 |
Ejemplares similares
-
SAT-052 A Novel Oral Testosterone Therapy (TLANDO) Safely Restores Testosterone to Eugonadal Levels with Fixed Dose Treatment
por: DelConte, Anthony, et al.
Publicado: (2020) -
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
por: DelConte, Anthony, et al.
Publicado: (2022) -
SAT-038 Ambulatory Blood Pressure Increases in Hypogonadal Men Who Develop Increases in Hematocrit on Oral Testosterone Undecanoate
por: Dobs, Adrian Sandra, et al.
Publicado: (2020) -
TLANDO, a Novel Oral TRT, Improves Sexual and Mental Domain Outcomes in Hypogonadal Men
por: Bruno, Benjamin J, et al.
Publicado: (2021) -
Efficacy and Safety of TLANDO, A Novel Oral Easy to Prescribe and Use TRT Option
por: Papangkorn, Kongnara, et al.
Publicado: (2021)